FDA advisers back Novavax COVID-19 shots as new US option

South Africa News News

FDA advisers back Novavax COVID-19 shots as new US option
South Africa Latest News,South Africa Headlines
  • 📰 mercnews
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 68%

Novavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company.

FDA’s vaccine chief Dr. Peter Marks said another choice in the U.S. may entice at least some vaccine holdouts — whatever their reason — to consider rolling up their sleeves.

Tuesday’s question: Do the benefits of two primary doses of the Novavax vaccine outweigh any risks? The FDA advisory panel voted that they do, by a 21-0 vote with one abstention. This type of vaccine “we think generates a broad immune response against a broad array of variants,” he told the FDA advisory panel.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

mercnews /  🏆 88. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA advisory panel to consider approving fourth COVID-19 vaccine, this one from Maryland's NovavaxFDA advisory panel to consider approving fourth COVID-19 vaccine, this one from Maryland's NovavaxDevelopment of the vaccine, from Novavax, a Gaithersburg, Maryland-based company, was started at the same time as others in 2020, but the company struggled to produce its shot in large quantities.
Read more »

Novavax Covid-19 Vaccine Faces FDA Advisers’ ScrutinyNovavax Covid-19 Vaccine Faces FDA Advisers’ ScrutinyThe outside panel of experts will vote on whether the shot should be authorized, after the agency found it effective but flagged a safety concern.
Read more »

Novavax Covid Vaccine Clears Key Step on Path to FDA Authorization After Committee Endorses the ShotNovavax Covid Vaccine Clears Key Step on Path to FDA Authorization After Committee Endorses the ShotNovavax’s shot would be the fourth Covid vaccine authorized for use in the U.S. The shots use different technology than Pfizer and Moderna.
Read more »

FDA advisers meeting on Novavax, a latecomer in COVID-19 vaccine raceFDA advisers meeting on Novavax, a latecomer in COVID-19 vaccine raceA federal advisory committee will vote on whether regulators should authorize a COVID-19 vaccine made by Novavax. From The New York Times.
Read more »

FDA panel to review Novavax candidate as potential fourth vaccine for adult Americans, and Pete Buttigieg tests positive for COVIDFDA panel to review Novavax candidate as potential fourth vaccine for adult Americans, and Pete Buttigieg tests positive for COVIDAn advisory panel to the U.S. Food and Drug Administration is due to meet later Tuesday to review the vaccine developed by Novavax Inc. as a potential fourth...
Read more »

Novavax Faces High Stakes FDA Review This Week That Will Decide the Fate of Its Covid Vaccine in the U.S.Novavax Faces High Stakes FDA Review This Week That Will Decide the Fate of Its Covid Vaccine in the U.S.The Food and Drug Administration’s independent experts will review the safety and effectiveness of Novavax’s Covid vaccine Tuesday. If they endorse the vaccine, the FDA will almost certainly authorize the shot for adults in the U.S. Novavax’s vaccine uses protein technology that is different Pfizer and Moderna’s messenger RNA shots. Novavax was part of the U.S. race to develop a…
Read more »



Render Time: 2025-03-04 15:10:40